{"filing":{"accession_number":"0000818479-26-000200","cik":"0000818479","ticker":"XRAY","company_name":"DENTSPLY SIRONA Inc.","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"xray-20260611.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847926000200/xray-20260611.htm"},"events":[{"id":5253,"run_id":4604,"accession_number":"0000818479-26-000200","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.94,"summary":"The Board appointed John C. Fortson as Executive Vice President \u0026 Chief Financial Officer, effective July 20, 2026, with a base salary of $780,000, target bonus of 85%, sign-on payments, and equity awards. This represents a material change in senior leadership responsible for financial management and reporting.","company_name":"DENTSPLY SIRONA Inc.","ticker":"XRAY","filing_date":"2026-06-11","form":"8-K","submitted_at":null,"items":[{"id":6122,"accession_number":"0000818479-26-000200","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The Board appointed John C. Fortson as Executive Vice President \u0026 Chief Financial Officer, effective July 20, 2026. While the disclosure includes compensatory details (base salary of $780,000, target bonus of 85%, sign-on payments, and equity awards), the principal disclosed action is the appointment of a named executive to a C-suite officer position. This is material to investors as it represents a change in senior leadership responsible for financial management and reporting.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T12:33:08.654919+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6123,"accession_number":"0000818479-26-000200","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mr. Fortson as Executive Vice President \u0026 Chief Financial Officer, a senior executive role. While disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive appointment of a named officer to a material position, which would affect investor assessment of the company's leadership and financial management.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T12:33:08.654919+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6122,"accession_number":"0000818479-26-000200","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The Board appointed John C. Fortson as Executive Vice President \u0026 Chief Financial Officer, effective July 20, 2026. While the disclosure includes compensatory details (base salary of $780,000, target bonus of 85%, sign-on payments, and equity awards), the principal disclosed action is the appointment of a named executive to a C-suite officer position. This is material to investors as it represents a change in senior leadership responsible for financial management and reporting.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T12:33:08.654919+00:00","company_name":"DENTSPLY SIRONA Inc.","ticker":"XRAY","filing_date":"2026-06-11"},{"id":6123,"accession_number":"0000818479-26-000200","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Mr. Fortson as Executive Vice President \u0026 Chief Financial Officer, a senior executive role. While disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive appointment of a named officer to a material position, which would affect investor assessment of the company's leadership and financial management.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T12:33:08.654919+00:00","company_name":"DENTSPLY SIRONA Inc.","ticker":"XRAY","filing_date":"2026-06-11"}]}